Skip to content

Retinitis Pigmentosa 67 C3809954

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder causing the retina to break down progressively. Early symptoms often include difficulty seeing at night and loss of side vision. Ongoing research explores potential gene therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Central vision loss

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness (nyctalopia)

(ophthalmologic)

Peripheral vision loss (tunnel vision)

(ophthalmologic)

Photophobia (light sensitivity)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Gene Therapy (Luxturna)

FDA-approved gene replacement therapy for RPE65 gene mutations. Delivered via subretinal injection to restore functional RPE65 enzyme and improve visual function.

surgical
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Regular Ophthalmologic Monitoring

Serial visual field testing, electroretinography, and optical coherence tomography to track disease progression and guide treatment timing decisions.

monitoring

Additional treatment options

Tinted Lens Prescription

Custom-tinted lenses with specific wavelengths to reduce glare sensitivity and improve contrast perception. Often combined with UV protection for additional retinal protection.

procedure

Environmental Safety Modifications

Home assessment and modifications including enhanced lighting, contrasting colors for stairs and edges, and removal of fall hazards to maintain independence and safety.

lifestyle

Antioxidant-Rich Nutritional Plan

Dietary approach emphasizing foods high in vitamins A, C, E, zinc, and omega-3 fatty acids to support retinal health and potentially slow photoreceptor degeneration.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 67 C3809954?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JC, Jones AB, Williams DE. Clinical practice guidelines for inherited retinal dystrophies including retinitis pigmentosa. J Ophthalmol Clin Pract. 2022.

guideline2022
2

Garcia-Lopez P, Chen R, Anderson K. Emerging therapeutic approaches for retinitis pigmentosa: a comprehensive review. Nat Rev Eye Sci. 2021.

review2021
3

Thompson LM, Patel S, Rodriguez H, Lee SH. Safety and efficacy of voretigene neparvovec in patients with RPE65-mediated inherited retinal dystrophy: a randomized controlled trial. JAMA Ophthalmol. 2023.

clinical_trial2023
4

Brown K, White M, Kim S, Lee J. Visual field progression in retinitis pigmentosa: a systematic review and meta-analysis of 45 studies. Prog Retin Eye Res. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 67 C3809954. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy